Remove 2013 Remove Leads Remove Pharmaceutical products
article thumbnail

Taming cardiovascular risk: the promise of LDL cholesterol lowering therapeutics

European Pharmaceutical Review

In this Q&A, he explores the trends and challenges within the cardiovascular treatment space, as well as clinical development of the company’s lead candidate obicetrapib, a cholesterol ester transfer protein (CETP) inhibitor for lowering low-density lipoprotein-cholesterol (LDL-C) and ultimately reducing cardiovascular risk.

Pharma 97
article thumbnail

Pharmaceutical microbiology: key developments 2022

European Pharmaceutical Review

The other side is the pipeline of new pharmaceutical products. She leads the AZ Global Microbiology Forum, bringing together the global network of microbiology labs to drive standardisation and quality principles in microbiology. About the authors.